You are here

  • Home
  • Archive
  • Volume 10, Issue 2
  • Targeting KDM4C enhances CD8+ T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Targeting KDM4C enhances CD8+ T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer

 

Online download statistics by month:

Online download statistics by month: February 2022 to July 2025

AbstractFullPdf
Feb 2022730751285
Mar 2022346355234
Apr 2022184190100
May 2022196212158
Jun 2022171177113
Jul 2022222226113
Aug 202223224099
Sep 2022217235130
Oct 2022206220116
Nov 202215315491
Dec 202212512562
Jan 202314014072
Feb 202317017196
Mar 2023155157100
Apr 202312012076
May 202313013081
Jun 2023808163
Jul 2023858581
Aug 2023787850
Sep 2023868658
Oct 2023979764
Nov 202312212272
Dec 202310310468
Jan 2024149150114
Feb 2024818265
Mar 2024142144115
Apr 2024111112102
May 2024858662
Jun 2024929365
Jul 202411311865
Aug 20247372106
Sep 2024889065
Oct 202410110164
Nov 2024959665
Dec 202411511677
Jan 202511011574
Feb 202510910981
Mar 2025140141102
Apr 202513213266
May 202511211394
Jun 2025484937
Jul 2025110
Total604561763801